National Institute for Health and Care Excellence
Approved cancer drugs and treatments such as radiotherapy and chemotherapy are funded by the NHS without any financial contribution being taken from the patient. Where NICE has approved a treatment, the NHS must fund it. But not all treatments have been assessed by NICE and these treatments are usually dependent on local NHS decision making. In the case of cancer the Cancer Drugs Fund was set up in 2011 after complaints about NICE decisions on new and expensive cancer drugs with limited benefits. Treatment for fertility problems are approved but not always funded by clinical commissioning groups and they may cap the number of rounds.
Cancer Treatment Centers of America
Cancer Treatment Centers of America also provide cancer specific centers for the following diseases at select locations:In addition, Cancer Treatment Centers of America offers several clinical trials at all five of their hospitals and is an active participate in studies offered through clinicaltrials.gov program. In 2016, CTCA offered the TAPUR study also known as the Targeted Agent and Profiling Utilization Registry study. This was led by the American Society of Clinical Oncology (ASCO). The study aimed to improve our understanding of how commercially available anti-cancer drugs perform on a broader range of cancers, by matching the drugs to tumors with specific genomic mutations that the drugs are designed to target.